20-Jan-2026
Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million
Globe Newswire (Tue, 6-Jan 8:00 AM ET)
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation
Globe Newswire (Mon, 5-Jan 8:00 AM ET)
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
Globe Newswire (Tue, 30-Dec 8:00 AM ET)
Globe Newswire (Tue, 23-Dec 9:08 AM ET)
Sidoti Events, LLC's Year-End Virtual Investor Conference
ACCESS Newswire (Tue, 9-Dec 12:48 PM ET)
Prenetics Announces Upcoming Conference Participation
Globe Newswire (Tue, 25-Nov 8:49 AM ET)
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
Globe Newswire (Mon, 24-Nov 7:30 AM ET)
Globe Newswire (Fri, 14-Nov 8:35 AM ET)
Globe Newswire (Mon, 10-Nov 7:24 AM ET)
Globe Newswire (Tue, 4-Nov 4:05 PM ET)
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
Prenetics Global Limited - Class A Ordinary Share trades on the NASDAQ stock market under the symbol PRE.
As of January 20, 2026, PRE stock price climbed to $16.23 with 323,530 million shares trading.
PRE has a beta of 0.68, meaning it tends to be less sensitive to market movements. PRE has a correlation of 0.02 to the broad based SPY ETF.
PRE has a market cap of $273.13 million. This is considered a Small Cap stock.
Last quarter Prenetics Global Limited - Class A Ordinary Share reported $24 million in Revenue and -$.41 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$.12.
In the last 3 years, PRE traded as high as $24.75 and as low as $2.85.
The top ETF exchange traded funds that PRE belongs to (by Net Assets): IWC, BCOR.
PRE has outperformed the market in the last year with a price return of +187.0% while the SPY ETF gained +14.6%. However, in the short term, PRE had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.1% vs +1.2% return in SPY. But in the last 2 weeks, PRE shares have fared better than the market returning -0.4% compared to SPY -2.1%.
PRE support price is $15.05 and resistance is $16.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRE shares will trade within this expected range on the day.